This suggests that IL‐2‐Fc treatment causes a stronger initial antitumor immune response than ICK due to far better elimination of Tregs, but ICK appears to maintain this response better in the long term mainly by increased IFNγ+CD8+ T cell tumor infiltration. This evidence concerns the gene CD8A and neoplasm.